Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALPRO: Valproic Acid and Fear Memory Reactivation in Spider Phobia
NCT02789813Phase 2Completed
- Start
- Jul 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of valproic acid in specific phobia (4 arms). Primary endpoint: Change in performance in Behavioral Approach Test in real-life at 90 days. Started Jul 2016; status: completed.
02
Drugs
valproic acid
03
Conditions
specific phobia
Beyond the preview
Go deeper on NCT02789813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02789813.